Provided by Tiger Trade Technology Pte. Ltd.

Accendra Health Inc

1.20
-0.1100-8.40%
Post-market: 1.20-0.0019-0.16%19:36 EDT
Volume:1.69M
Turnover:2.07M
Market Cap:92.29M
PE:-0.30
High:1.31
Open:1.28
Low:1.18
Close:1.31
52wk High:5.69
52wk Low:0.9337
Shares:76.90M
Float Shares:56.51M
Volume Ratio:0.53
T/O Rate:2.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9457
EPS(LYR):-14.3179
ROE:-198.35%
ROA:0.64%
PB:-0.17
PE(LYR):-0.08

Loading ...

Accendra Health updates capital allocation, CEO succession plans

TIPRANKS
·
Aug 17

Accendra Health Sells First of Two Non-Core Assets, Expects About $45 Million Cash Injection

Reuters
·
Aug 17

Accendra Health - Sale of Two Non-Core Assets to Provide $45 Mln Cash Injection in Q3 and Q4

THOMSON REUTERS
·
Aug 17

Accendra Health - Will not Implement At-the-Market Issuance Program

THOMSON REUTERS
·
Aug 17

Accendra Health - Board Expects to Announce CEO Successor by Mid-September 2026

THOMSON REUTERS
·
Aug 17

Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans

THOMSON REUTERS
·
Aug 17

Accendra Health Inc : UBS Cuts Target Price to $1.5 from $4.5

THOMSON REUTERS
·
Aug 14

Accendra Health is Maintained at Neutral by UBS

Dow Jones
·
Aug 14

UBS Adjusts Price Target on Accendra Health to $1.50 From $4.50, Keeps Neutral Rating

MT Newswires Live
·
Aug 13

U.S. Research Roundup-Airbnb, Five Below, Silgan Holdings

Reuters
·
Aug 13

Press Release: Chemtrade Logistics Income Fund Announces Results for the Second Quarter of 2026 and Reiterates 2026 Adjusted Ebitda Guidance of $485 to $525 Million

Dow Jones
·
Aug 13

Accendra Health Cut to Neutral from Buy by Citigroup

Dow Jones
·
Aug 11

Citigroup Downgrades Accendra Health to Neutral From Buy, Adjusts PT to $1.50 From $4.50

MT Newswires Live
·
Aug 11

Baird Downgrades Accendra Health to Neutral From Outperform, Adjusts PT to $1.50 From $6

MT Newswires Live
·
Aug 11

U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics

Reuters
·
Aug 11

Accendra Health Inc : Baird Cuts to Neutral Rating; Cuts Target Price to $1.5 from $6

THOMSON REUTERS
·
Aug 11

US Closing Bell | Megacaps resist mild pullback as Dow edges 0.1% lower

US Closing Bell
·
Aug 11

Accendra Health Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10

Accendra Health Shares Slip on Sales-View Cut, Impending CEO Exit

Dow Jones
·
Aug 10

Accendra Health Says Q2 2026 Results Miss Forecast on Weaker Revenue Growth, Slower Collections Recovery

Reuters
·
Aug 10